These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 21585245)

  • 41. Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis.
    Krajina T; Leithäuser F; Möller P; Trobonjaca Z; Reimann J
    Eur J Immunol; 2003 Apr; 33(4):1073-83. PubMed ID: 12672074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of IL-12 and IL-23 on antigen-presenting cells at the interface between innate and adaptive immunity.
    Puccetti P; Belladonna ML; Grohmann U
    Crit Rev Immunol; 2002; 22(5-6):373-90. PubMed ID: 12803317
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential IL-23 requirement for IL-22 and IL-17A production during innate immunity against Salmonella enterica serovar Enteritidis.
    Siegemund S; Schütze N; Schulz S; Wolk K; Nasilowska K; Straubinger RK; Sabat R; Alber G
    Int Immunol; 2009 May; 21(5):555-65. PubMed ID: 19297659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?
    Lubberts E
    Cytokine; 2008 Feb; 41(2):84-91. PubMed ID: 18039580
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoimmune inflammation from the Th17 perspective.
    Furuzawa-Carballeda J; Vargas-Rojas MI; Cabral AR
    Autoimmun Rev; 2007 Jan; 6(3):169-75. PubMed ID: 17289553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intracellular network of phosphatidylinositol 3-kinase, mammalian target of the rapamycin/70 kDa ribosomal S6 kinase 1, and mitogen-activated protein kinases pathways for regulating mycobacteria-induced IL-23 expression in human macrophages.
    Yang CS; Song CH; Lee JS; Jung SB; Oh JH; Park J; Kim HJ; Park JK; Paik TH; Jo EK
    Cell Microbiol; 2006 Jul; 8(7):1158-71. PubMed ID: 16819968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Promotion of the local differentiation of murine Th17 cells by synovial macrophages during acute inflammatory arthritis.
    Egan PJ; van Nieuwenhuijze A; Campbell IK; Wicks IP
    Arthritis Rheum; 2008 Dec; 58(12):3720-9. PubMed ID: 19035489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of IL 23 in the treatment of psoriasis.
    Puig L
    Expert Rev Clin Immunol; 2017 Jun; 13(6):525-534. PubMed ID: 28165883
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview.
    Schinocca C; Rizzo C; Fasano S; Grasso G; La Barbera L; Ciccia F; Guggino G
    Front Immunol; 2021; 12():637829. PubMed ID: 33692806
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-canonical interleukin 23 receptor complex assembly: p40 protein recruits interleukin 12 receptor β1 via site II and induces p19/interleukin 23 receptor interaction via site III.
    Schröder J; Moll JM; Baran P; Grötzinger J; Scheller J; Floss DM
    J Biol Chem; 2015 Jan; 290(1):359-70. PubMed ID: 25371211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Guselkumab for the Treatment of Psoriasis.
    Machado Á; Torres T
    BioDrugs; 2018 Apr; 32(2):119-128. PubMed ID: 29470778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Employing an IL-23 p19 vaccine to block IL-23 ameliorates chronic murine colitis.
    Guan Q; Burtnick HA; Qing G; Weiss CR; Ma AG; Ma Y; Warrington RJ; Peng Z
    Immunotherapy; 2013 Dec; 5(12):1313-22. PubMed ID: 24283842
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does p40-targeted therapy represent a significant evolution in the management of plaque psoriasis?
    Griffiths CE; Girolomoni G
    J Eur Acad Dermatol Venereol; 2012 Aug; 26 Suppl 5():2-8. PubMed ID: 22758911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reciprocal Regulation of Substance P and IL-12/IL-23 and the Associated Cytokines, IFNγ/IL-17: A Perspective on the Relevance of This Interaction to Multiple Sclerosis.
    Vilisaar J; Kawabe K; Braitch M; Aram J; Furtun Y; Fahey AJ; Chopra M; Tanasescu R; Tighe PJ; Gran B; Pothoulakis C; Constantinescu CS
    J Neuroimmune Pharmacol; 2015 Sep; 10(3):457-67. PubMed ID: 25690155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin-12 (IL-12), but not IL-23, induces the expression of IL-7 in microglia and macrophages: implications for multiple sclerosis.
    Jana M; Mondal S; Jana A; Pahan K
    Immunology; 2014 Apr; 141(4):549-63. PubMed ID: 24224652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ustekinumab in psoriasis immunopathology with emphasis on the Th17-IL23 axis: a primer.
    Quatresooz P; Hermanns-Lê T; Piérard GE; Humbert P; Delvenne P; Piérard-Franchimont C
    J Biomed Biotechnol; 2012; 2012():147413. PubMed ID: 22754278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural basis for the dual recognition of IL-12 and IL-23 by ustekinumab.
    Luo J; Wu SJ; Lacy ER; Orlovsky Y; Baker A; Teplyakov A; Obmolova G; Heavner GA; Richter HT; Benson J
    J Mol Biol; 2010 Oct; 402(5):797-812. PubMed ID: 20691190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Specific targeting of the IL-23 receptor, using a novel small peptide noncompetitive antagonist, decreases the inflammatory response.
    Quiniou C; Domínguez-Punaro M; Cloutier F; Erfani A; Ennaciri J; Sivanesan D; Sanchez M; Chognard G; Hou X; Rivera JC; Beauchamp C; Charron G; Vilquin M; Kuchroo V; Michnick S; Rioux JD; Lesage S; Chemtob S
    Am J Physiol Regul Integr Comp Physiol; 2014 Nov; 307(10):R1216-30. PubMed ID: 25354400
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.
    Cua DJ; Sherlock J; Chen Y; Murphy CA; Joyce B; Seymour B; Lucian L; To W; Kwan S; Churakova T; Zurawski S; Wiekowski M; Lira SA; Gorman D; Kastelein RA; Sedgwick JD
    Nature; 2003 Feb; 421(6924):744-8. PubMed ID: 12610626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ustekinumab: The "New Kid on the Block" in the Treatment of Psoriatic Arthritis.
    Torres T; Faria R
    Drug Dev Res; 2015 Dec; 76(8):428-31. PubMed ID: 26372543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.